BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Branchi I, Poggini S, Capuron L, Benedetti F, Poletti S, Tamouza R, Drexhage HA, Penninx BWJH, Pariante CM; European College of Neuropsychopharmacology (ECNP) ImmunoNeuroPsychiatry Thematic Working Group and Marion Leboyer. Brain-immune crosstalk in the treatment of major depressive disorder. Eur Neuropsychopharmacol 2021;45:89-107. [PMID: 33386229 DOI: 10.1016/j.euroneuro.2020.11.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Benedetti F, Palladini M, Paolini M, Melloni E, Vai B, De Lorenzo R, Furlan R, Rovere-Querini P, Falini A, Mazza MG. Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study. Brain Behav Immun Health 2021;18:100387. [PMID: 34746876 DOI: 10.1016/j.bbih.2021.100387] [Reference Citation Analysis]
2 Kofod J, Elfving B, Nielsen EH, Mors O, Köhler-Forsberg O. Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis. Eur Neuropsychopharmacol 2021:S0924-977X(21)00756-2. [PMID: 34598835 DOI: 10.1016/j.euroneuro.2021.09.006] [Reference Citation Analysis]
3 Branchi I, Giuliani A. Shaping therapeutic trajectories in mental health: Instructive vs. permissive causality. European Neuropsychopharmacology 2021;43:1-9. [DOI: 10.1016/j.euroneuro.2020.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Simonato M, Dall'Acqua S, Zilli C, Sut S, Tenconi R, Gallo N, Sfriso P, Sartori L, Cavallin F, Fiocco U, Cogo P, Agostinis P, Aldovini A, Bruttomesso D, Marcolongo R, Comai S, Baritussio A. Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Biomedicines 2021;9:1724. [PMID: 34829952 DOI: 10.3390/biomedicines9111724] [Reference Citation Analysis]
5 Benedetti F, Zanardi R, Mazza MG. Antidepressant psychopharmacology: is inflammation a future target? International Clinical Psychopharmacology 2022;37:79-81. [DOI: 10.1097/yic.0000000000000403] [Reference Citation Analysis]
6 Benedetti F, Dallaspezia S, Melloni EMT, Lorenzi C, Zanardi R, Barbini B, Colombo C. Effective Antidepressant Chronotherapeutics (Sleep Deprivation and Light Therapy) Normalize the IL-1β:IL-1ra Ratio in Bipolar Depression. Front Physiol 2021;12:740686. [PMID: 34539454 DOI: 10.3389/fphys.2021.740686] [Reference Citation Analysis]
7 Miola A, Dal Porto V, Tadmor T, Croatto G, Scocco P, Manchia M, Carvalho AF, Maes M, Vieta E, Sambataro F, Solmi M. Increased C-reactive protein concentration and suicidal behavior in people with psychiatric disorders: A systematic review and meta-analysis. Acta Psychiatr Scand 2021. [PMID: 34292580 DOI: 10.1111/acps.13351] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Luning Prak ET, Brooks T, Makhoul W, Beer JC, Zhao L, Girelli T, Skarke C, Sheline YI. No increase in inflammation in late-life major depression screened to exclude physical illness. Transl Psychiatry 2022;12:118. [PMID: 35332134 DOI: 10.1038/s41398-022-01883-4] [Reference Citation Analysis]
9 Milaneschi Y, Kappelmann N, Ye Z, Lamers F, Moser S, Jones PB, Burgess S, Penninx BWJH, Khandaker GM. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry 2021. [PMID: 34135474 DOI: 10.1038/s41380-021-01188-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Drevets WC, Wittenberg GM, Bullmore ET, Manji HK. Immune targets for therapeutic development in depression: towards precision medicine. Nat Rev Drug Discov 2022. [PMID: 35039676 DOI: 10.1038/s41573-021-00368-1] [Reference Citation Analysis]
11 Comai S, Melloni E, Lorenzi C, Bollettini I, Vai B, Zanardi R, Colombo C, Valtorta F, Benedetti F, Poletti S. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression. Eur Neuropsychopharmacol 2021;55:96-109. [PMID: 34847455 DOI: 10.1016/j.euroneuro.2021.11.003] [Reference Citation Analysis]
12 Baune BT, Sampson E, Louise J, Hori H, Schubert KO, Clark SR, Mills NT, Fourrier C. No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial. Eur Neuropsychopharmacol 2021;53:34-46. [PMID: 34375789 DOI: 10.1016/j.euroneuro.2021.07.092] [Reference Citation Analysis]